MXCT.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 10:57):

Stats
Dzisiejszy wolumen	17 146.00
Średni wolumen	27 145.00
Kapitalizacja rynkowa	331.85M
EPS	£0 ( 2024-05-06 )
Następna data zysków	( £0 ) 2024-06-21
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-10.95
ATR14	£0 (0.00%)

MaxCyte Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MaxCyte Inc Finanse

Annual	2023
Przychody:	£41.29M
Zysk brutto:	£36.55M (88.51 %)
EPS:	£-0.370

FY	2023
Przychody:	£41.29M
Zysk brutto:	£36.55M (88.51 %)
EPS:	£-0.370

FY	2022
Przychody:	£44.26M
Zysk brutto:	£39.16M (88.48 %)
EPS:	£-0.190

FY	2021
Przychody:	£33.89M
Zysk brutto:	£30.25M (89.24 %)
EPS:	£-0.210

Financial Reports:

No articles found.

MaxCyte Inc

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.